Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

456

HTML

3888

Figures (1-6)

279

Tables (1-5)

222

Sum=4845

Dec 14, 2008 (publication date) through Nov 15, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 14, 2008; 14(46): 7033-7058
Published online Dec 14, 2008. doi: 10.3748/wjg.14.7033

Table 1 Rodent models of intrahepatic cholangiocarcinoma constitutively overexpressing ErbB2/Neu in cancerous epithelium

Model	Tumor			ErbB2/Neu			Tyrosine phosphorylation	Ref.
Model	Development time	Incidence (%)	Classification	c-erbB-2/neu	mRNA	Protein	Tyrosine phosphorylation	Ref.
Furan rat model	> 1 yr	70-100	Intestinal-type cholangiocarcinoma	Wild-type/non-amplified	Increased	Increased	Increased	[63,64]
Thioacetamide rat model	16-22 wk	100	Intestinal-type cholangiocarcinoma	NA	NA	Increased	NA	[65]
P53 deficiency/CCl₄ mouse model	≥ 16 wk	40	Ductal cholangiocarcinoma	NA	NA	Increased	NA	[66]
Rat BDEneu orthotopic cell transplantation model	4 wk	100	Ductal cholangiocarcinoma	Mutated	Increased	Increased	Increased	[68,69]

NA: Not assessed.

Citation: Sirica AE. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma. World J Gastroenterol 2008; 14(46): 7033-7058
URL: https://www.wjgnet.com/1007-9327/full/v14/i46/7033.htm
DOI: https://dx.doi.org/10.3748/wjg.14.7033